CAROLINA GUTIERREZ to Chemotherapy, Adjuvant
This is a "connection" page, showing publications CAROLINA GUTIERREZ has written about Chemotherapy, Adjuvant.
Connection Strength
0.042
-
A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer. Clin Breast Cancer. 2015 Apr; 15(2):101-9.
Score: 0.026
-
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008 May 07; 100(9):672-9.
Score: 0.016